BIO REFERENCE LABORATORIES INC 4
4 · BIO REFERENCE LABORATORIES INC · Filed Aug 20, 2015
Insider Transaction Report
Form 4
GRODMAN MARC
DirectorPresident, CEO10% Owner
Transactions
- Disposition to Issuer
Common Stock
2015-08-20−200,000→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2015-08-20−200,000→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2015-08-20−1,937,502→ 0 total - Disposition to Issuer
Common Stock
2015-08-20−159,464→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2015-08-20−244,834→ 0 total(indirect: By Spouse)
Footnotes (5)
- [F1]As of the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated as of June 3, 2015 (the "Merger Agreement"), by and among the Issuer, OPKO Health, Inc., a Delaware corporation ("OPKO"), and Bamboo Acquisition, Inc., a New Jersey corporation, each share of the Issuer's common stock held by the reporting person was disposed of pursuant to the Merger Agreement in exchange for 2.75 shares of OPKO common stock.
- [F2]Represents shares held in a successor trust to a grantor retained annuity trust of which Pam Gau Grodman, the reporting person's spouse, and Rich Faherty are trustees.
- [F3]Represents 145,834 shares directly owned by the reporting person's wife and 99,000 shares owned by their children. The reporting person disclaims beneficial ownership of these 244,834 shares.
- [F4]Represents 200,000 shares held in trust for the benefit of the reporting person's wife and children, of which the reporting person and Mr. Ariel Fuentes are the co-trustees.
- [F5]Represents 200,000 shares held in trust for the benefit of the reporting person and children, of which the reporting person's wife is the trustee.